Medicare Approves UM Medical Center For Lung Transplants

January 13, 1998

The federal Health Care Financing Administration has designated the University of Maryland Medical Center as a Medicare-approved lung transplant center, which means that elderly patients who need the surgery no longer have to travel outside the mid-Atlantic region.

The University of Maryland Medical Center becomes the only Medicare-approved lung transplant center between Philadelphia and Durham, NC. It is the 24th in the nation. The designation covers patients who need single, double or combined heart-lung transplantation.

HCFA conducts a rigorous evaluation process before accepting a program for Medicare reimbursement. A medical center must perform at least 10 lung transplants a year for two years and must have a one-year patient survival rate above 63 percent.

At the University of Maryland Medical Center, where 38 lung transplants have been performed in the past two years, the one-year patient survival rate is 84 percent.

"The designation enables us to help more patients, especially those who live in the Baltimore-Washington area who otherwise would have to travel several hours away from home for their transplant," says John V. Conte, M.D., director of heart-lung transplant surgery at the University of Maryland Medical Center. According to the Transplant Resource Center of Maryland, there are more than 70 Marylanders on the waiting list for a lung or heart-lung transplant. Nationally, there are almost 2,800.

The University of Maryland Medical Center offers all of the advanced medical and surgical treatments available for patients with advanced lung disease, including transplantation, lung volume reduction surgery for emphysema and therapies for pulmonary hypertension.

University of Maryland Medical Center

Related Lung Transplant Articles from Brightsurf:

Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death
Antifungal preventive medications reduce mortality risk by half in the first year following lung transplantation, according to Mayo Clinic research involving 667 patients who received lung transplants from 2005 to 2018.

Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital stays
Remote, real-time monitoring of post-operative lung transplant patients significantly decreases hospital readmissions and resulted in shorter hospital stays when patients were readmitted

New research finds signal of decreased early post transplant survival in new heart transplant system
In an analysis of the new heart organ allocation system for transplant patients in the US, researchers have identified a signal of a decrease in heart transplant survival rates.

Inhaled immunosuppressant may increase survival, pulmonary function after lung transplant
University of Maryland School of Medicine researchers found that lung transplant recipients who had early signs of organ rejection could increase their chances of survival by inhaling a liposomal form of the immunosuppression drug cyclosporine through an investigational nebulizer.

Little-used drug combination may extend the lives of lung transplant patients
Median survival after lung transplant is less than six years.

Lung cell transplant boosts healing after the flu in mice
A serious case of the flu can cause lasting damage to the lungs.

Clinical trial shows promise for increasing lung transplant patients' life expectancy
A new study shows that a potential treatment for ischemia- reperfusion injury is safe for humans.

New clues discovered to lung transplant rejection
Researchers at Washington University School of Medicine in St. Louis have discovered clues to a particularly deadly form of rejection that can follow lung transplantation.

Blood test shows promise for early detection of severe lung-transplant rejection
Researchers have developed a simple blood test that can detect when a newly transplanted lung is being rejected by a patient, even when no outward signs of the rejection are evident.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Read More: Lung Transplant News and Lung Transplant Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to